ויפידיה 12.5 מ"ג - Vipidia 12.5 mg

×©××× ××Â !
××ª×¨××¤× × ×¢××× ×:××××¨ ××ª×¨××¤××ª ×©× ××©×¨× ×××¨××××ª.
×× ××ª×§××× ××××¢× ×¢× ××¤×¡×§×ª ×©××××§ ××ª×¨××¤× ×:××¢×¨××ª ×××××¢××ª ×¢× ××¤×¡×§×ª ×©××××§ ×ª×¨××¤××ª.
×ª××¨×× ×¢×××× ×××¨×× ××ª×¨××¤× ×× ××××§××ª×¨××¤××ª ××× 15/05/19.

× ×ª×× × ×ª×¨××¤×

×××¨×©×

××× ×× ×× × ××¡×¤××	×××¤×××× 25 ×"× - Vipidia 25 mg ×××¤×××× 6.25 ×"× - Vipidia 6.25 mg
×§×××¦× ×¤×¨××§××××××ª (ATC4)	A10BH Dipeptidyl peptidase 4 (DPP-4) inhibitors
××¨××× ×¤×¢×× (ATC5)	Â Alogliptin AS BENZOATE 12.5MG âA10BH04
×¦××¨×ª ××ª×	×¤××× - PER OS
×¦××¨×ª ××× ××	××××××ª ××¦××¤××ª ×¤×××, FILM COATED TABLETS ××× ××¢×ª ××× ×× ××ª×¨ ×× ××¨×¢×× ××© ××××× ××ª ××ª×¨××¤× ×××ª×× ×××× ×× ××××××¥ ××¤× ×©×××¤××¢ ××¢××× ××¦×¨××
××ª××××	Vipidia is indicated in adults aged 18 years and older with type 2 diabetes mellitus to improve glycaemic control in combination with other glucose lowering medicinal products including insulin, when these, together with diet and exercise, do not provide adequate glycaemic control.
×¢××× ××¨××¤× ×××××¨××ª ××¢×××	××× ×¢××× ××¨××¤× Â

×¢××× ××¦×¨××	Â

×¢×¨××× ×××××§××¨×¤×××	×¢×¨××× ×§×©××¨×× ×××××§××¨×¤×××
[ ×××¤×××× 12.5 ×"×] ×××××¨ ××©×¨× ×××¨××××ª

השינוי האחרון נעשה בֹ־20 במאי 2023 ב־12:51

ויקיתרופות